Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

437 recalls, newest first

Class II · Moderate risk

Zonisamide Capsules

cGMP deviations

Completed cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-130-01 D-0793-2022
Class II · Moderate risk

Zonisamide Capsules

cGMP deviations

Completed cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-129-01 D-0792-2022
Class II · Moderate risk

Trulicity (dulaglutide)

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions

Completed Temperature excursion Cardinal Health Inc. NDC 0002-1433-80 D-0884-2022
Class II · Moderate risk

Trulicity (dulaglutide)

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

Completed Temperature excursion Cardinal Health Inc. NDC 00002-1434-80 D-0883-2022
Class I · High risk

Humalog KwikPen

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

Completed Temperature excursion Cardinal Health Inc. NDC 0002-8799-59 D-0882-2022
Class II · Moderate risk

Milk of Magnesia USP

CGMP Deviations: Failure to properly investigate failed microbial testing.

Completed Microbial contamination Plastikon Healthcare LLC NDC 0904-6846-73 D-0870-2022
Class I · High risk

Methocarbamol 500mg Tablet

Labeling: Label Error on Declared Strength; Bottles labeled as Methocarbamol 500 mg Tablets actually contain Methocarbamol 750 mg Tablets

Completed Labeling / mix-up Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals D-0092-2022
Class II · Moderate risk

Valproic Acid Oral Solution USP

CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.

Completed Microbial contamination Morton Grove Pharmaceuticals, Inc. D-0816-2021
Class II · Moderate risk

Promethazine Syrup Plain

CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.

Completed Microbial contamination Morton Grove Pharmaceuticals, Inc. D-0814-2021

Recalls by year